Lowest P/E Healthcare stocks
Healthcare companies worth over $1 billion with the lowest price-to-earnings ratio (positive earnings only). A low P/E can mean cheap, or earnings the market expects to fall.
Top of the list: Innoviva (INVA) 3.26x; Lakefront Biotherapeutics NV (LKFT) 3.29x; Novavax (NVAX) 4.30x.
The median p/e across these 50 companies is 15.2x.
| # | Company | P/E | P/FCF | Market cap | Revenue growth | Net margin |
|---|---|---|---|---|---|---|
| 1 | Innoviva IncINVA | 3.26x | 7.68x | $1.5B | +19.2% | 81.2% |
| 2 | Lakefront Biotherapeutics NVLKFT | 3.29x | — | $1.9B | +303.5% | 28.9% |
| 3 | Novavax IncNVAX | 4.30x | — | $2.1B | -76.3% | -59.9% |
| 4 | BioCryst Pharmaceuticals IncBCRX | 6.52x | 6.10x | $2.0B | +33.6% | -40.9% |
| 5 | PTC Therapeutics IncPTCT | 6.69x | 7.31x | $5.1B | +101.5% | -3.8% |
| 6 | Universal Health Services IncUHS | 7.21x | 12.3x | $10.4B | +8.3% | 8.4% |
| 7 | Aurinia Pharmaceuticals IncAUPH | 7.27x | 15.4x | $2.1B | +18.9% | 100.8% |
| 8 | Novo Nordisk A/SNVO | 8.53x | 5.56x | $161.1B | +6.4% | 33.1% |
| 9 | ACADIA Pharmaceuticals IncACAD | 8.64x | 31.1x | $3.3B | +16.4% | 33.4% |
| 10 | Solventum Corp.SOLV | 10.9x | — | $15.5B | +2.2% | 17.3% |
| 11 | Grifols SA ADRGRFS | 11.1x | 7.11x | $5.3B | +9.4% | 2.2% |
| 12 | Cigna CorpCI | 11.1x | 8.45x | $70.9B | +6.7% | 2.3% |
| 13 | Fresenius Medical Care CorporationFMS | 11.2x | 6.81x | $11.5B | -0.3% | 5.0% |
| 14 | Ardent Health Partners, Inc.ARDT | 11.3x | 5.98x | $1.5B | -1.4% | 1.2% |
| 15 | Prestige Brand Holdings IncPBH | 11.4x | 8.32x | $2.1B | +6.5% | 15.6% |
| 16 | Aveanna Healthcare Holdings IncAVAH | 11.5x | 26.5x | $3.0B | +13.7% | 10.6% |
| 17 | Mednax IncMD | 11.6x | 7.79x | $2.0B | +4.0% | 9.0% |
| 18 | GlaxoSmithKline PLC ADRGSK | 12.3x | 16.0x | $93.4B | +4.1% | 17.5% |
| 19 | Zoetis IncZTS | 13.0x | 14.6x | $33.3B | -0.2% | 27.5% |
| 20 | Tenet Healthcare CorporationTHC | 13.2x | 8.65x | $21.9B | +6.8% | 10.3% |
| 21 | HCA Holdings IncHCA | 14.7x | 12.3x | $94.7B | +4.3% | 8.9% |
| 22 | Amphastar PAMPH | 14.8x | 8.92x | $1.1B | +5.4% | 10.8% |
| 23 | Omeros CorporationOMER | 15.0x | — | $1.2B | — | — |
| 24 | Organon & CoOGN | 15.0x | 6.80x | $3.7B | -2.3% | 3.4% |
| 25 | ADMA Biologics IncADMA | 15.0x | 85.1x | $2.4B | +2.0% | 33.0% |
| 26 | Incyte CorporationINCY | 15.4x | 16.1x | $21.8B | +20.9% | 26.7% |
| 27 | Bausch Health Companies IncBHC | 15.4x | 2.31x | $2.3B | +12.7% | -10.1% |
| 28 | Phibro Animal Health CorporationPAHC | 15.8x | 35.6x | $1.5B | +4.8% | 6.6% |
| 29 | Inspire Medical Systems IncINSP | 15.9x | 26.6x | $2.1B | -7.6% | 15.0% |
| 30 | Regeneron Pharmaceuticals IncREGN | 16.0x | 16.8x | $68.5B | +16.7% | 27.9% |
| 31 | GE HealthCare Technologies Inc.GEHC | 16.4x | 20.6x | $31.0B | +7.4% | 9.1% |
| 32 | Harmony Biosciences HoldingsHRMY | 16.5x | 6.82x | $2.4B | +30.3% | 18.9% |
| 33 | Bristol-Myers Squibb CompanyBMY | 16.7x | 9.50x | $122.0B | +5.7% | 18.9% |
| 34 | TG Therapeutics IncTGTX | 17.1x | — | $7.5B | +70.3% | 55.2% |
| 35 | DaVita HealthCare Partners IncDVA | 17.3x | 8.80x | $11.5B | +5.2% | 6.0% |
| 36 | Elevance Health IncELV | 17.3x | 28.0x | $88.9B | +1.4% | 2.5% |
| 37 | Boston Scientific CorpBSX | 17.8x | 17.2x | $63.1B | +7.5% | 17.5% |
| 38 | Sanofi ADRSNY | 17.9x | 9.72x | $98.6B | — | — |
| 39 | Indivior PLC Ordinary SharesINDV | 17.9x | — | $4.1B | +13.6% | 26.6% |
| 40 | ANI Pharmaceuticals IncANIP | 18.2x | 9.46x | $1.6B | +25.9% | 11.1% |
| 41 | Globus MedicalGMED | 18.4x | 18.2x | $10.7B | +5.9% | 17.0% |
| 42 | Exelixis IncEXEL | 18.8x | 16.9x | $14.3B | +10.6% | 35.3% |
| 43 | Haleon plcHLN | 19.4x | 21.4x | $42.1B | -1.8% | 15.1% |
| 44 | TransMedics Group IncTMDX | 19.7x | 22.2x | $3.0B | +20.7% | 22.7% |
| 45 | United Therapeutics CorporationUTHR | 19.8x | 21.9x | $22.8B | -1.9% | 41.6% |
| 46 | AptarGroup IncATR | 20.1x | 24.9x | $7.5B | +6.3% | 9.2% |
| 47 | Novartis AG ADRNVS | 20.1x | 15.6x | $275.6B | — | — |
| 48 | Gilead Sciences IncGILD | 20.2x | 19.5x | $184.1B | +10.2% | -10.6% |
| 49 | Addus HomeCare CorporationADUS | 20.3x | 19.8x | $2.1B | +8.0% | 7.1% |
| 50 | Encompass Health CorpEHC | 20.6x | 27.1x | $11.9B | +9.6% | 10.0% |
Ranked from each company's latest price and reported results. Companies need a page on Investingly (SEC statements on file). Open any company for its reverse DCF, insider buying and 13F holders.
Other sectors
More valuation lists
Questions
Which company ranks first on the lowest p/e healthcare stocks list?
Innoviva (INVA), with a p/e of 3.26x, as of October 12, 2026.
How is this list built?
US companies worth over $1 billion with the lowest price-to-earnings ratio (positive earnings only). A low P/E can mean cheap, or earnings the market expects to fall. It shows the top 50 and is rebuilt every day.
Prices and ratios as of Oct 11, 2026. Statements from SEC filings. Information only, not investment advice.